Current Vascular Pharmacology
Title:Editorial : Full Blood Count and Peripheral Arterial Disease Severity and Prognosis
Volume: 15 Issue: 2
Author(s): Konstantinos Spanos, Miltiadis Matsagkas and Athanasios Giannoukas
Affiliation:
Export Options
About this article
Cite this article as:
Spanos Konstantinos, Matsagkas Miltiadis and Giannoukas Athanasios, Editorial : Full Blood Count and Peripheral Arterial Disease Severity and Prognosis, Current Vascular Pharmacology 2017; 15 (2) . https://dx.doi.org/10.2174/1570161114999161019110003
DOI https://dx.doi.org/10.2174/1570161114999161019110003 |
Print ISSN 1570-1611 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6212 |
Call for Papers in Thematic Issues
TREATMENT OF CARDIOVASCULAR DISEASE IN CHRONIC AND END STAGE KIDNEY DISEASE
Cardiovascular disease still remains the leading cause of death in Chronic and End Stage Kidney Disease, accounting for more than half of all deaths in dialysis patients. During the past decade, research has been focused on novel therapeutic agents that might delay or even reverse cardiovascular disease and vascular calcification, ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Acute Ischemic Cerebrovascular Events on Antiplatelet Therapy: What is the Optimal Prevention Strategy?
Current Pharmaceutical Design MR Imaging Findings of Uterine Cervical Carcinoma
Current Medical Imaging Effect of Intravitreal Injection of Aflibercept on Cardiovascular Risk Parameters in Patients with Neovascular Age-Related Macular Degeneration
Current Reviews in Clinical and Experimental Pharmacology Cardiovascular Risk and Endothelial Dysfunction: The Preferential Route for Atherosclerosis
Current Pharmaceutical Biotechnology PDE5 Inhibitors in Non-Urological Conditions
Current Pharmaceutical Design Toxicity of Carbon Nanotubes
Current Drug Metabolism The Effect of DPP-4i on Endothelial Function and Arterial Stiffness in Patients with Type 2 Diabetes: A Systematic Review of Randomized Placebo-controlled Trials
Current Pharmaceutical Design Angiotensin-Converting Enzyme Inhibitors: Mechanisms of Action and Implications In Anesthesia Practice
Current Pharmaceutical Design Patent Selections
Recent Patents on Medical Imaging Coagulation and Cancer Therapy: The Potential of Natural Compounds
Current Genomics Antioxidant Capacities of Flavones and Benefits in Oxidative-Stress Related Diseases
Current Topics in Medicinal Chemistry Non-Surgical Treatment Options for Symptomatic Uterine Leiomyomas
Current Women`s Health Reviews Bi-3-Azaoxoisoaporphine Derivatives have Antidepressive Properties in a Murine Model of Post Stroke-Depressive Like Behavior
Current Neurovascular Research New Vectors and Strategies for Cardiovascular Gene Therapy
Current Gene Therapy Mechanisms of Thrombosis, Available Treatments and Management Challenges Presented by Thromboangiitis Obliterans
Current Medicinal Chemistry Neopterin: From Forgotten Biomarker to Leading Actor in Cardiovascular Pathophysiology
Current Vascular Pharmacology Intravitreal Bevacizumab (Avastin®) for Diabetic Retinopathy at 24-months: The 2008 Juan Verdaguer-Planas Lecture
Current Diabetes Reviews Spontaneous Pneumothorax
Current Respiratory Medicine Reviews Inflammation and Chronic Oxidative Stress in Radiation-Induced Late Normal Tissue Injury: Therapeutic Implications
Current Medicinal Chemistry Ethanol Induced Oxidative Stress in the Vasculature: Friend or Foe
Current Hypertension Reviews